Latest "Neural Substrates in Nicotine Withdrawal" News Stories

20:05 EST 20th January 2019 | BioPortfolio

Here are the most relevant search results for "Neural Substrates in Nicotine Withdrawal" found in our extensive news archives from over 250 global news sources.

More Information about Neural Substrates in Nicotine Withdrawal on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Neural Substrates in Nicotine Withdrawal for you to read. Along with our medical data and news we also list Neural Substrates in Nicotine Withdrawal Clinical Trials, which are updated daily. BioPortfolio also has a large database of Neural Substrates in Nicotine Withdrawal Companies for you to search.

Showing "Neural Substrates Nicotine Withdrawal" News Articles 1–25 of 954

Friday 18th January 2019

Autifony Therapeutics achieves first milestone in agreement with Boehringer Ingelheim for a novel therapeutic approach to a range of CNS disorders

Stevenage, UK – 18 January 2019 – Autifony Therapeutics Limited (“Autifony”), a clinical stage company developing new drugs to treat serious disorders of the nervous system, today announced that the first milestone has successfully been achieved under Autifony’s option agreement with Boehringer Ingelheim. As announced previously, Boehringer Ingelheim acquired an exc...

Thursday 17th January 2019

Why Vaping Is So Dangerous for Teens

(CNN) – Most of what we know about nicotine addiction in teens, we know from cigarettes. But experts say the technology and chemistry of vaping might pose an entirely different threat. “It turns out that e-cigarette use by kids doesn’t … Read More

Novel microscopy method enables high-resolution study of neural brain circuits

A novel imaging technique combining two microscopy methods allowed researchers to visualize neural circuits across the brain at four-times that of typical resolutions, according to research published Jan. 17 in Science. The approach can be completed much faster than previously thought possible.

Ironshore Pharmaceuticals Announces Appointment of Dr. Lewis Warrington as Vice President / Head of Medical Affairs

Ironshore Pharmaceuticals, Inc. (“Ironshore”), a wholly owned subsidiary of Highland Therapeutics Inc. (“Highland”) and a leader in the commercialization of novel treatments for

Activating cannabinoid receptors in a newly identified neural circuit ameliorates depressive-like behaviors in mice: #CBD #depression

Activating cannabinoid receptors in a newly identified neural circuit ameliorates depressive-like behaviors in mice: #CBD #depression

As Teen Vaping Epidemic Continues To Increase, No Therapy Exists To Help Break Addiction

The anti-smoking therapies on the market — such as nicotine patches and gums — are not approved for children. Teens who become addicted will just need to have ''discipline" to quit, some experts say. In other news on the epidemic, researchers say e-cigarettes seem to be more appealing to teens than tobacco and are causing more serious problems.

DowDuPont Specialty Products Division to Spotlight Newly Combined Healthcare Portfolio at MD&M West 2019

Complementary silicone- and polymer-based technologies offer unique design solutions for industry trends impacting patients and clinicians WILMINGTON, Del. (PRWEB) January 17, 2019 DowDuPont Specialty Products Division will showcase its recently combined portfolio of innovative, healthcare product technologies and solutions in booth #3001/3005 at MD&M West in Anaheim, California, Feb. 5-7, 20...

Interacting neural ensembles in orbitofrontal cortex for social and feeding behaviour

Scientists search for new methods to cure neurodegenerative diseases

Most neurons in the human brain are generated from neural stem cells during embryonic development. After birth, a small reservoir of stem cells remains in the brain that keeps on producing new neurons throughout life. However, the question arises as to whether these new neurons really support brain function? And if so, can we improve brain capacity by increasing the number of neurons? A research g...

Wednesday 16th January 2019

Increasing the Rate of Smoking Cessation in the United States

This Viewpoint argues that adoption of a combination of varenicline, nicotine replacement therapy, and behavioral support as first-line treatment for tobacco addiction could increase smoking cessation rates in the United States and proposes that varenicline be made an over-the-counter medication to help more smokers quit cigarettes and improve population health.

New findings reveal surprising role of the cerebellum in reward and social behaviors

(NIH/National Institute of Mental Health) A study in rodents found that the brain's cerebellum -- known to play a role in motor coordination -- also helps control the brain's reward circuitry. Researchers found a direct neural connection from the cerebellum to the ventral tegmental area (a brain area long known to be involved in reward processing and encoding). The findings shed light on the brain...

Study Finds the Circuits That May Help You Keep Your Cool

NewsBy explaining more about how the brain keeps arousal in check, the study might also provide insight into the neural mechanisms contributing to anxiety or chronic stress,

Pharma comments on Brexit withdrawal rejection

Pharmaceutical groups weigh in on the UK parliament’s rejection of the Brexit withdrawal agreement.

EpiVario Secures Exclusive Worldwide License for Novel Technologies and Drugs for Memory-Related Psychiatric Diseases from University of Pennsylvania

Company acquires full rights, in all fields, for novel drug to treat memory-related psychiatric disorders, such as post-traumatic stress disorder (PTSD) PHILADELPHIA (PRWEB) January 16, 2019 EpiVario, an early-stage drug discovery and development company, today announced it has secured an exclusive worldwide license, in all fields, for novel technologies and drug candidates for a wide range of me...

Pharmacy sector 'deploying all necessary resources' to prevent Brexit medicines shortages, as government deal voted down

Following the historic parliamentary defeat of the government’s Brexit withdrawal agreement, the Pharmaceutical Services Negotiating Committee has said it is “deploying all necessary resources” to ensure patients do not run short of medicines when the UK leaves the EU.

After MPs Reject Brexit Deal, UK ABPI Wants Solution 'Quickly'

Following the government’s defeat over the Brexit withdrawal deal, the life sciences industry wants the UK parliament to fi...

Tuesday 15th January 2019

Pharmaceutical groups weigh in on UK parliament rejection of Brexit withdrawal agreement®ion_id=6 …

Pharmaceutical groups weigh in on UK parliament rejection of Brexit withdrawal agreement …

Lexaria Bioscience Announces Partnership with Altria to Fund Research and Development of DehydraTECH(tm) Technology for Oral Nicotine

Lexaria Bioscience Corp. (CSE:LXX,OCTQX:LXRP) ( "Lexaria Bioscience"), a drug delivery platform innovator, is pleased to announce that its wholly-owned subsidiary Lexaria Nicotine LLC ("Lexaria Nicotine") and Altria Ventures Inc., an indirect wholly owned subsidiary of Altria Group, Inc. (NYSE:MO) ("Altria"), have executed definitive agreements to pursue innovation in oral, reduced risk nicotine c...

ArunA Bio Appoints Dr. Mark Sirgo as Chief Executive Officer

-- Dr. Steven Stice to Continue Leading Company’s Research and Manufacturing Operations -- ArunA Bio, a leader in the development of exosomes for the treatment of CNS and neurodegenerative disorders, today announced the appointment of Mark Sirgo, Pharm.D. as Chief Executive Officer. Dr. Sirgo joins the company with more than 35 years of pharma...

A selective ER-phagy exerts procollagen quality control via a Calnexin-FAM134B complex

Autophagy is a cytosolic quality control process that recognizes substrates through receptor-mediated mechanisms. Procollagens, the most abundant gene products in Metazoa, are synthesized in the endoplasmic reticulum (ER), and a fraction that fails to attain the native structure is cleared by autophagy. However, how autophagy selectively recognizes misfolded procollagens in the ER lumen is still u...

Miro proteins prime mitochondria for Parkin translocation and mitophagy

The Parkinson's disease-associated protein kinase PINK1 and ubiquitin ligase Parkin coordinate the ubiquitination of mitochondrial proteins, which marks mitochondria for degradation. Miro1, an atypical GTPase involved in mitochondrial trafficking, is one of the substrates tagged by Parkin after mitochondrial damage. Here, we demonstrate that a small pool of Parkin interacts with Miro1 before mitoc...

Clearwater Periodontist Weighs in on Vaping and Oral Health

Clearwater periodontist Dr. Todd Britten warns that he is seeing softer enamel, increased plaque and drier mouths with patients using e-cigarettes and vaporizers, which will lead to more gum disease and tooth decay. CLEARWATER, Fla. (PRWEB) January 15, 2019 “Here in our Clearwater periodontal office, we have noticed that many young people and other patients feel that compared to traditional tob...

Monday 14th January 2019

Buprenorphine Prescribing Restrictions in the Opioid Epidemic

Dr Hanson makes a strong argument for why buprenorphine should be considered in the ED after an opioid-related overdose or withdrawal. Medscape Emergency Medicine

Sunday 13th January 2019

Functioning Human Neural Networks Grown in 3D from Stem Cells

Functioning Human Neural Networks Grown in 3D from Stem Cells Reporter: Irina Robu, PhD   Researchers at Tuffs University developed three-dimensional human tissue model that mimics structural and functional features of the brain and were able to demonstrate sustained neural activity over several months. The 3D brain tissue models were the result of a collaborative […]

Friday 11th January 2019

Monogamy May Be Written in our Genes

In animal studies, a set of 24 genes involved in neural development, learning and memory, and cognition, seem to be associated with monogamy. Karen Hopkin reports. -- Read more on

Quick Search


News Quicklinks